Actively Recruiting
Observational Study on Early-Stage Polycystic Kidney Disease Collecting Blood and Urine to Discover Biomarkers for Disease Progression
Led by University of Kansas Medical Center · Updated on 2026-04-27
250
Participants Needed
3
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting an observational study to collect blood, urine, and clinical information from people with early stages of polycystic kidney disease PKD, their unaffected siblings, and healthy volunteers. The main goal is to build a biobank to discover biological markers, or biomarkers, that signal changes in disease progression. Understanding these early markers can help improve monitoring and treatment as new therapies are developed for PKD. The study involves three groups individuals diagnosed with early-stage PKD based on kidney volume and kidney filtration rate, unaffected or undiagnosed family members preferably siblings, and normal volunteers without a family history of kidney disease. Participants will provide blood and urine samples which researchers will use for basic and translational research over a 10-year period. Participants will be asked to provide samples and clinical information at regular intervals to help researchers study early cyst growth and kidney tissue damage that current tests cannot detect. The study tracks important measures like kidney function and total kidney volume. This long-term research aims to support the discovery of new tests to better predict disease progression and monitor responses to future treatments. The study is open to individuals aged 4 to 35 years and includes healthy volunteers.
CONDITIONS
Brief Title
Early PKD Observational Cohort Study
Research Team
C
Cathy Creed, RN
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here